Terms: = Germ cell tumor AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814
125 results:
1. Global, Regional, and National Incidence Trend Analysis of Malignant Skin Melanoma Between 1990 and 2019, and Projections Until 2034.
Yuan J; Li X; Yu S
Cancer Control; 2024; 31():10732748241227340. PubMed ID: 38227397
[TBL] [Abstract] [Full Text] [Related]
2. epas1-mutated paragangliomas associated with haemoglobin disorders.
Mancini M; Buffet A; Porte B; Amar L; Lussey-Lepoutre C; Crinière L; Baudin E; Meatchi T; Gimenez-Roqueplo AP; Favier J; Burnichon N
Br J Haematol; 2024 Mar; 204(3):1054-1060. PubMed ID: 38195958
[TBL] [Abstract] [Full Text] [Related]
3. Congenital Cyanotic Heart Disease and the Association with Pheochromocytomas and Paragangliomas.
Jones RB; Cohen DL
Curr Cardiol Rep; 2023 Nov; 25(11):1451-1460. PubMed ID: 37847359
[TBL] [Abstract] [Full Text] [Related]
4. Case Report: A novel
Yang H; Chen Y; Liu K; Zhao L
Front Endocrinol (Lausanne); 2023; 14():1180091. PubMed ID: 37576964
[TBL] [Abstract] [Full Text] [Related]
5. Somatic epas1 Variants in Pheochromocytoma and Paraganglioma in Patients With Sickle cell Disease.
White G; Nonaka D; Chung TT; Oakey RJ; Izatt L
J Clin Endocrinol Metab; 2023 Nov; 108(12):3302-3310. PubMed ID: 37285480
[TBL] [Abstract] [Full Text] [Related]
6. A Young Patient with Undiagnosed Polycythemia-Paraganglioma Syndrome: A Case Report.
Alaklabi AM; Arabi TZ; Bin Saeedan MN; Alotaibi GS
Am J Case Rep; 2023 May; 24():e938676. PubMed ID: 37160900
[TBL] [Abstract] [Full Text] [Related]
7. Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy.
Atkinson TM; Hay JL; Young Kim S; Schofield E; Postow MA; Momtaz P; Warner AB; Shoushtari AN; Callahan MK; Wolchok JD; Li Y; Chapman PB
Oncologist; 2023 Apr; 28(4):351-357. PubMed ID: 36745014
[TBL] [Abstract] [Full Text] [Related]
8. [Clinicopathological analysis of superior mediastinal lymph node metastases in medullary thyroid carcinoma].
He YY; Chen YT; Wang J; Chen MQ; Zhu YM; Ni S; Liu SY
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):82-87. PubMed ID: 36709124
[No Abstract] [Full Text] [Related]
9. Comprehensive
Karaghiannis V; Maric D; Garrec C; Maaziz N; Buffet A; Schmitt L; Antunes V; Airaud F; Aral B; Le Roy A; Corbineau S; Mansour-Hendili L; Lesieur V; Rimbert A; Laporte F; Delamare M; Rab M; Bézieau S; Cassinat B; Galacteros F; Gimenez-Roqueplo AP; Burnichon N; Cario H; Van Wijk R; Bento C; Girodon F; Hoogewijs D; Gardie B
Haematologica; 2023 Jun; 108(6):1652-1666. PubMed ID: 36700397
[TBL] [Abstract] [Full Text] [Related]
10. Histone acetyltransferase 1 (HAT1) acetylates hypoxia-inducible factor 2 alpha (hif2a) to execute hypoxia response.
Kumar N; Mondal M; Arathi BP; Sundaresan NR; Somasundaram K
Biochim Biophys Acta Gene Regul Mech; 2023 Mar; 1866(1):194900. PubMed ID: 36410688
[TBL] [Abstract] [Full Text] [Related]
11. Paraganglioma with High Levels of Dopamine, Dopa Decarboxylase Suppression, Dopamine β-hydroxylase Upregulation and Intra-tumoral Melanin Accumulation: A Case Report with a Literature Review.
Nezu M; Hirotsu Y; Amemiya K; Tateno T; Takizawa S; Inoue M; Mochizuki H; Hosaka K; Chik C; Oyama T; Omata M
Intern Med; 2023 Jul; 62(13):1895-1905. PubMed ID: 36384901
[TBL] [Abstract] [Full Text] [Related]
12. Somatic IDH1 Hotspot Variants in Chinese Patients With Pheochromocytomas and Paragangliomas.
Li M; He Y; Pang Y; Zhang J; Feng Y; He Y; Xu X; Wei Y; Zhong D; Deng W; Wang L; Yan B; Jiang Y; Xu N; Cai H; Wen Y; Ning J; Liu Y; Gao X; Shan Z; Liu L; Teng X; Richter S; Jiang J
J Clin Endocrinol Metab; 2023 Apr; 108(5):1215-1223. PubMed ID: 36355572
[TBL] [Abstract] [Full Text] [Related]
13. Pseudohypoxia in paraganglioma and pheochromocytoma is associated with an immunosuppressive phenotype.
Celada L; Cubiella T; San-Juan-Guardado J; Gutiérrez G; Beiguela B; Rodriguez R; Poch M; Astudillo A; Grijalba A; Sánchez-Sobrino P; Tous M; Navarro E; Serrano T; Paja M; Valdés N; Chiara MD
J Pathol; 2023 Jan; 259(1):103-114. PubMed ID: 36314599
[TBL] [Abstract] [Full Text] [Related]
14. Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization.
Yi GZ; Zhu TC; Que TS; Li ZY; Huang GL
BMC Neurol; 2022 Oct; 22(1):390. PubMed ID: 36271359
[TBL] [Abstract] [Full Text] [Related]
15. Novel germline
Provenzano A; Chetta M; De Filpo G; Cantini G; La Barbera A; Nesi G; Santi R; Martinelli S; Rapizzi E; Luconi M; Maggi M; Mannelli M; Ercolino T; Canu L
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013579
[TBL] [Abstract] [Full Text] [Related]
16. Targeted Therapies in Pheochromocytoma and Paraganglioma.
Wang K; Crona J; Beuschlein F; Grossman AB; Pacak K; Nölting S
J Clin Endocrinol Metab; 2022 Nov; 107(11):2963-2972. PubMed ID: 35973976
[TBL] [Abstract] [Full Text] [Related]
17. Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805384
[TBL] [Abstract] [Full Text] [Related]
18. Genetic Analysis of Pheochromocytoma and Paraganglioma Complicating Cyanotic Congenital Heart Disease.
Ogasawara T; Fujii Y; Kakiuchi N; Shiozawa Y; Sakamoto R; Ogawa Y; Ootani K; Ito E; Tanaka T; Watanabe K; Yoshida Y; Kimura N; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S
J Clin Endocrinol Metab; 2022 Aug; 107(9):2545-2555. PubMed ID: 35730597
[TBL] [Abstract] [Full Text] [Related]
19. Preclinical evaluation of targeted therapies in Sdhb-mutated tumors.
Moog S; Salgues B; Braik-Djellas Y; Viel T; Balvay D; Autret G; Robidel E; Gimenez-Roqueplo AP; Tavitian B; Lussey-Lepoutre C; Favier J
Endocr Relat Cancer; 2022 May; 29(6):375-388. PubMed ID: 35348472
[TBL] [Abstract] [Full Text] [Related]
20. Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
Wang K; Schütze I; Gulde S; Bechmann N; Richter S; Helm J; Lauseker M; Maurer J; Reul A; Spoettl G; Klink B; William D; Knösel T; Friemel J; Bihl M; Weber A; Fankhauser M; Schober L; Vetter D; Broglie Däppen M; Ziegler CG; Ullrich M; Pietzsch J; Bornstein SR; Lottspeich C; Kroiss M; Fassnacht M; Wenter VUJ; Ladurner R; Hantel C; Reincke M; Eisenhofer G; Grossman AB; Pacak K; Beuschlein F; Auernhammer CJ; Pellegata NS; Nölting S
Endocr Relat Cancer; 2022 May; 29(6):285-306. PubMed ID: 35324454
[TBL] [Abstract] [Full Text] [Related]
[Next]